Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 5
Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
Received 22 December 2011
Accepted for publication 1 February 2012
Published 7 May 2012 Volume 2012:5 Pages 39—42
DOI https://doi.org/10.2147/CCID.S23269
Review by Single anonymous peer review
Peer reviewer comments 3
Omar Pacha, Adelaide A Hebert
Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA
Abstract: Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of this epidermal component through topically applied ceramide based emollients appears to be safe, well tolerated, and effective. Recently a ceramide hyaluronic acid foam has become commercially available and increasing evidence supports its safety and efficacy in patients who suffer from atopic dermatitis.
Keywords: atopic dermatitis, ceramide, Hylatopic, eczema, non-steroidal, dermatology
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.